The U.S. bioscience industry continued to score employment gains through 2008 - the first year of the recent economic downturn, according to a study released today by Battelle and the Biotechnology Industry Organization (BIO). The Battelle/BIO State Bioscience Initiatives 2010 contains the most recent data available and shows that publicly traded bioscience-related companies on the whole generated positive net growth through 2009.
U.S. employment in the bioscience sector reached 1.42 million in 2008, a gain of 19,000 bioscience industry jobs in the United States since 2007.
The report is a compendium of national, state and metropolitan data on bioscience employment and growth trends from 2001 to 2008, according to the latest detaled industry data to be released by the U.S. Bureau of Labor Statistics. It also presents a series of key bioscience performance metrics and state policy and program trends that are designed to accelerate the growth of the biosciences.
For the first time since Battelle began to produce the report for BIO, included is a national examination of the financial performance of the biosciences sector.
This 2010 report presents the following:
Data on national, state, and metropolitan bioscience employment and growth trends from 2001 to 2008, with a 1 year view into how the biosciences have fared in the midst of the current recession
National and state-level data on bioscience research and development (R&D), venture capital investments, patents, degrees awarded, employment by occupation and clinical trials activity
An examination at the national level of the financial performance of the bioscience sector, which addresses its long?term sustainability and growth.
These data are presented for all 50 states, the District of Columbia, and Puerto Rico. Battelle is the world's largest independent research and development organization and produces the report with support from BIO.